Physician profile
Cadrin E Gill
NPI 1891851861
$2,816.52
in general payments reported to CMS, 2019-2025
22 companies · $1,289 in 2025
The $1,289 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.52 · 2020: $116 · 2021: $197 · 2022: $471 · 2023: $401 · 2024: $265 · 2025: $1,289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,226 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,225.74 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $730.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $730.00 | 2025 | Korlym |
| Lilly USA, LLC | $397.75 | 2020-2025 | Mounjaro, Zepbound, Trulicity |
| Astrazeneca Pharmaceuticals LP | $287.96 | 2024-2025 | Airsupra, Breztri |
| Viiv Healthcare Company | $240.61 | 2023-2025 | Apretude |
| Abbott Laboratories | $159.69 | 2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $155.68 | 2019-2023 | Shingrix, Bexsero |
| Novo Nordisk INC | $140.31 | 2022-2024 | Wegovy |
| Gilead Sciences, INC. | $131.33 | 2021-2022 | |
| Heron Therapeutics, INC. | $112.12 | 2022 | |
| Novartis Pharmaceuticals Corporation | $106.07 | 2019-2022 | |
| Pfizer INC. | $63.20 | 2022-2023 | |
| Dexcom, INC. | $41.59 | 2022 | |
| Cranial Technologies, INC | $37.07 | 2023-2025 | Doc Band |
| Vertex Pharmaceuticals Incorporated | $36.34 | 2023 | |
| Merck Sharp & Dohme LLC | $31.07 | 2025 | Proquad, Gardasil 9, Capvaxive |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $23.68 | 2025 | Thinprep 2000 Processor, Aptima |
| Lundbeck LLC | $23.35 | 2023 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $23.06 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.50 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $19.23 | 2022 | |
| Bausch Health US, LLC | $19.00 | 2020 | |
| Sanofi Pasteur INC. | $15.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cadrin Gill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.